← back to search

Andreas Obermair

The University of Queensland · AU
Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Uterine Myomas and Treatments, and Cancer survivorship and care.
h-index
62
citations
14,938
works
458
NIH funding
primary concept
Medicine
email

Recent publications

Changes and trends in endometrial cancer patterns of care: a scoping review of the literature from 2000 to 2024
International Journal of Gynecological Cancer 2026cited by 2position: contributordoi
Efficacy of ultrasound in the evaluation of inguinal lymph nodes in patients with vulvar cancer: an updated systematic review and meta-analysis
International Journal of Gynecological Cancer 2026cited by 1position: contributordoi
Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intra-uterine device for endometrial hyperplasia and adenocarcinoma: results from the feMMe phase 2 randomized clinical trial
International Journal of Gynecological Cancer 2026cited by 1position: contributordoi
Response to: Correspondence on “Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial” by Baxter et al.
International Journal of Gynecological Cancer 2026cited by 0position: contributordoi
Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial
International Journal of Gynecological Cancer 2026cited by 0position: contributordoi
Response to correspondence on “Considerations on Interpreting Temporal Trends in a Scoping Review of Endometrial Cancer Care”
International Journal of Gynecological Cancer 2026cited by 0position: contributordoi
Sentinel lymph node biopsy in vulvar cancer: current evidence, limitations, and future perspectives
Journal of Gynecologic Oncology 2026cited by 0position: contributordoi
Sentinel lymph node biopsy compared to no nodal assessment in endometrial cancer: a systematic review
International Journal of Gynecological Cancer 2026cited by 0position: contributordoi
Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers.
2025cited by 4position: contributordoi
Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma
International Journal of Gynecological Cancer 2025cited by 3position: contributordoi
Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival-A prospective cohort study in Australia.
2025cited by 1position: contributordoi
Patterns of care for vulval cancer treatment: the Queensland experience
International Journal of Gynecological Cancer 2025cited by 1position: contributordoi
The impact of surgical complications on obstetricians' and gynecologists' well-being and coping mechanisms as second victims.
2025cited by 1position: contributordoi
Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery
International Journal of Gynecological Cancer 2025cited by 0position: contributordoi
The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery
2025cited by 0position: contributordoi
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Journal of Clinical Oncology 2024cited by 75position: lastdoi
Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
2024cited by 18position: contributordoi
Uterine transposition for fertility preservation in pelvic cancers.
2024cited by 13position: contributordoi
Controversies in the Surgical Management of Gynecologic Cancer: Balancing the Decision to Operate or Hesitate.
2024cited by 2position: contributordoi
Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers.
2024cited by 2position: contributordoi
Use of indocyanine green for ureteric illumination and visualization.
2024cited by 1position: contributordoi
Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trial.
2024cited by 1position: contributordoi
Mismatch repair status and surgical approach in apparent early-stage endometrial cancer.
2024cited by 0position: contributordoi
Learnings from implementing a surgical training program
2024cited by 0position: contributordoi
Patients’ experiences of vulvar cancer diagnosis and treatment: results from a consumer-guided qualitative study
Cancer Survivorship Research & Care 2024cited by 0position: contributordoi
Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study
Gynecologic Oncology 2023cited by 26position: middledoi
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.
2023cited by 10position: contributordoi
The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research.
2023cited by 5position: contributordoi
Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?
2023cited by 2position: contributordoi
Sentinel lymph node staging versus lymphadenectomy in high risk patients: is there sufficient evidence to change practice?
2023cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 37 papers (2019–2026)Monika Janda · Queensland Health18 papers (2017–2026)Val Gebski · Centre de recherche en Epidémiologie et Santé des Populations11 papers (2018–2024) · 8 papers (2019–2026)Eva Baxter · QIMR Berghofer Medical Research Institute6 papers (2021–2026)Penelope M. Webb · Clovis Oncology (United States)6 papers (2020–2025)George B. Hanna · Imperial College London5 papers (2019–2024)Kristy Robledo · The University of Sydney5 papers (2018–2024)Robert L. Coleman · MD Anderson Cancer Center Madrid4 papers (2018–2024)James Nicklin · The University of Queensland4 papers (2018–2021)Michael Frumovitz · The University of Texas MD Anderson Cancer Center4 papers (2018–2024)Anna deFazio · Beckman Research Institute4 papers (2020–2025)Mario M. Leitao · Cornell University4 papers (2023–2024)Alessandro Buda · Azienda Ospedaliera San Gerardo3 papers (2018–2024)Marcus Q. Bernardini · University Health Network3 papers (2020–2024)Rebecca Asher · University of Sydney3 papers (2018–2024)David Isla · Instituto Nacional de Cancerología3 papers (2018–2024)Pedro T. Ramírez · Houston Methodist3 papers (2018–2024)Linda Mileshkin · Peter MacCallum Cancer Centre3 papers (2020–2021)René Pareja · Gynecologic Oncology Group3 papers (2018–2024)